Literature DB >> 3874016

Evaluation of T cell subsets in Behçet's syndrome using anti-T cell monoclonal antibodies.

G Valesini, P Pivetti-Pezzi, F Mastrandrea, A Moncada, M Cuomo, P G Natali.   

Abstract

Several immunological abnormalities have been described in Behçet's syndrome, the multisystem disease characterized by the triad of relapsing iridocyclitis with recurrent oral and genital ulcerations. In the present study we have evaluated T cell subsets in the peripheral blood of patients suffering from Behçet's syndrome, using a panel of anti-T cell monoclonal antibodies. When compared with normal subjects, patients with Behçet's syndrome show a discrepancy between the number of T3+ cells and those forming rosettes with sheep erythrocytes, a significantly higher number of T4+ and T8+ double labelled cells, as well as of T6+ lymphocytes in the peripheral blood. The percentage of T8 T lymphocytes is increased, thus lowering the T4+/T8+ cell ratio. The results of this study indicate that a complex imbalance of T cell subsets is present in Behçet's syndrome and give a rationale for possible treatment of these patients with immunomodulators.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3874016      PMCID: PMC1576995     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Specific histocompatibility antigens associated with Behçet's disease.

Authors:  S Ono; E Nakayama; S Sugiura; K Itakura; K Aoki
Journal:  Am J Ophthalmol       Date:  1975-10       Impact factor: 5.258

2.  A monoclonal antibody with selective reactivity with functionally mature human thymocytes and all peripheral human T cells.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

3.  An improved rosetting assay for detection of human T lymphocytes.

Authors:  M E Kaplan; C Clark
Journal:  J Immunol Methods       Date:  1974-07       Impact factor: 2.303

4.  Characterization of mucosal antibodies in recurrent aphthous ulceration and Behcet's syndrome.

Authors:  T Lehner
Journal:  Arch Oral Biol       Date:  1969-07       Impact factor: 2.633

5.  Abnormalities of T-cell subsets in Behçet's syndrome.

Authors:  S D Lim; C R Haw; N I Kim; R M Fusaro
Journal:  Arch Dermatol       Date:  1983-04

6.  Circulating immune complexes in active Behçet's disease.

Authors:  R C Gupta; J D O'Duffy; F C McDuffie; M Meurer; R E Jordon
Journal:  Clin Exp Immunol       Date:  1978-11       Impact factor: 4.330

7.  Circulating soluble immume complexes in recurrent oral ulceration and Behçet's syndrome.

Authors:  R J Levinsky; T Lehner
Journal:  Clin Exp Immunol       Date:  1978-05       Impact factor: 4.330

8.  Acute phase proteins and C9 in patients with Behcet's syndrome and aphthous ulcers.

Authors:  M Adinolfi; T Lehner
Journal:  Clin Exp Immunol       Date:  1976-07       Impact factor: 4.330

9.  Immune complexes in Behçet's syndrome and recurrent oral ulceration.

Authors:  B D Williams; T Lehner
Journal:  Br Med J       Date:  1977-05-28

10.  Isolation and characterization of naturally occurring subclasses of human peripheral blood T cells with regulatory functions.

Authors:  A J Strelkauskas; V Schauf; B S Wilson; L Chess; S F Schlossman
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

View more
  7 in total

1.  Behçet's disease with a large intracardiac thrombus: a case report.

Authors:  M Baykan; S Celik; C Erdöl; E C Baykan; I Durmus; S Bahadir; H Erdöl; C Orem; H Cakirbay
Journal:  Heart       Date:  2001-04       Impact factor: 5.994

2.  Gammadelta T cells in Behçet's disease (BD) and recurrent aphthous stomatitis (RAS).

Authors:  J Freysdottir; S Lau; F Fortune
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

3.  Potent HIV-specific responses are enriched in a unique subset of CD8+ T cells that coexpresses CD4 on its surface.

Authors:  Andrew Zloza; Jason M Schenkel; Allan R Tenorio; Jeffrey A Martinson; Paul M Jeziorczak; Lena Al-Harthi
Journal:  Blood       Date:  2009-08-21       Impact factor: 22.113

4.  Circulating CD4+CD8+ T lymphocytes in patients with Kawasaki disease.

Authors:  J Hirao; K Sugita
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

5.  Increased circulating Ia-positive T cells in patients with idiopathic thrombocytopenic purpura.

Authors:  H Mizutani; T Tsubakio; Y Tomiyama; S Katagiri; T Tamaki; Y Kurata; T Yonezawa; S Tarui
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

6.  Upregulation of CD4 on CD8+ T cells: CD4dimCD8bright T cells constitute an activated phenotype of CD8+ T cells.

Authors:  Y B Sullivan; A L Landay; J A Zack; S G Kitchen; L Al-Harthi
Journal:  Immunology       Date:  2001-07       Impact factor: 7.397

7.  Cellular immunity in subacute thyroiditis: a new perspective through neopterin.

Authors:  Melisa Sahin Tekin; Evin Kocaturk; Sinem Gurcu; Huseyin Kayadibi; Bilge Dibeklioglu; Goknur Yorulmaz
Journal:  Clin Exp Immunol       Date:  2022-07-22       Impact factor: 5.732

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.